Fig. 1

Double lower limbs ulcers after relapse. a Before pembrolizumab. b Response to pembrolizumab after one cycle of treatment. c Ongoing response to pembrolizumab after four cycles of treatment
Double lower limbs ulcers after relapse. a Before pembrolizumab. b Response to pembrolizumab after one cycle of treatment. c Ongoing response to pembrolizumab after four cycles of treatment